top of page
Q4 warning letter roundup with Asa Waldstein
Asa Waldstein
Dec 20, 2022
In his quarterly update, consultant Asa Waldstein identifies trends in FDA warning letters impacting manufacturers and marketers of dietary supplements.
bottom of page